Drug Trial Radar · NCT06848075
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
431
Actual
Start
Mar 11, 2025
Primary completion
Aug 4, 2025
Study completion Aug 4, 2025
Sponsor
- Lead sponsor
- TriGemX Bio, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 26, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the acute treatment of migraine.
Conditions
- Migraine
Interventions
Elismetrep (K-304) 2 mgDrug
Administered orally
Elismetrep (K-304) 5 mgDrug
Administered orally
Elismetrep (K-304) 10 mgDrug
Administered orally
Elismetrep (K-304) 20 mgDrug
Administered orally
PlaceboDrug
Administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain FreedomTime frame: 2 hours post-dose
Locations
66 sites in 1 country. Site status is shown where the registry gives one.
Central Research Associates, LLC (CRA) dba Flourish Research
Birmingham, Alabama
AMR Mobile
Mobile, Alabama
Wake Research/ Tucson Neuroscience Research
Tucson, Arizona
Hope Clinical Research
Canoga Park, California
WR-PRI, LLC (Encino)
Encino, California
Marvel Clinical Research
Huntington Beach, California
Eximia Research - CA
La Mesa, California
Synergy San Diego
Lemon Grove, California
WR-PRI, LLC (Newport Beach)
Newport Beach, California
Excell Research, Inc.
Oceanside, California
Empire Clinical Research
Pomona, California
Artemis Institute for Clinical Research - Riverside
Riverside, California
Acclaim Clinical Research
San Diego, California
Artemis Institute for Clinical Research - San Diego
San Diego, California
Diablo Clinical Research, Inc.
Walnut Creek, California
Focus Clinical Research
West Hills, California
CT Clinical Research
Cromwell, Connecticut
DelRicht Research
Atlanta, Georgia
Clinical Research Atlanta - Stockbridge
Stockbridge, Georgia
Northwest Clinical Trials
Boise, Idaho
Cedar Crosse Research Center
Chicago, Illinois
Healthcare Research Network II, LLC
Flossmoor, Illinois
Collective Medical Research
Overland Park, Kansas
Alliance for Multispecialty Research
Wichita, Kansas
L-MARC Research Center
Louisville, Kentucky
Crescent City Headache & Neurology Center
Chalmette, Louisiana
DelRicht Research
New Orleans, Louisiana
Michigan Head Pain and Neurological Institute
Ann Arbor, Michigan
Clinical Research Institute
Minneapolis, Minnesota
DelRicht Research
Gulfport, Mississippi
Healthcare Research Network
Hazelwood, Missouri
Excel Clinical Research
Las Vegas, Nevada
Las Vegas Clinical Trials
North Las Vegas, Nevada
Albuquerque Clinical Trials, Inc.
Albuquerque, New Mexico
Dent Neurosciences Research Center
Amherst, New York
CNY Clinical Research
Manlius, New York
Rochester Clinical Research
Rochester, New York
Upstate Clinical Research Associates LLC
Williamsville, New York
Headache Wellness Center
Greensboro, North Carolina
Peters Medical Research
High Point, North Carolina
Showing 40 of 66 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.